A-423579

A-423579
	Stereo, Kekulé, skeletal formula of A-423,579 (({[(3R)-3-amino]}))
Names
	Preferred IUPAC name 4′-{3-[(3R)-3-(Dimethylamino)pyrrolidin-1-yl]propoxy}-3′,5′-difluoro[1,1′-biphenyl]-4-carbonitrile
Identifiers
CAS Number	461045-17-0 ;
3D model (JSmol)	Interactive image; Interactive image;
ChEMBL	ChEMBL498228 ;
ChemSpider	9524593 (R) ; 13210784 ;
PubChem CID	11349657 (R); 22994515;
UNII	Q2CW3V5WGF ;
CompTox Dashboard (EPA)	DTXSID90629426 ;
	InChI InChI=1S/C22H25F2N3O/c1-26(2)19-8-10-27(15-19)9-3-11-28-22-20(23)12-18(13-21(22)24)17-6-4-16(14-25)5-7-17/h4-7,12-13,19H,3,8-11,15H2,1-2H3/t19-/m1/s1 Key: DJXFZKXYKKBTDR-LJQANCHMSA-N ;
	SMILES CN(C)C1CCN(CCCOC2=C(F)C=C(C=C2F)C2=CC=C(C=C2)C#N)C1; CN(C)C1CCN(CCCOc2c(F)cc(cc2F):c2ccc(cc2)C#N)C1;
Properties
Chemical formula	C22H25F2N3O
Molar mass	385.4502 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

A-423,579 is one of a range of histamine antagonists developed by Abbott Laboratories which are selective for the H₃ subtype, and have stimulant and anorectic effects in animal studies making them potentially useful treatments for obesity. A-423,579 has improved characteristics over earlier drugs in the series with both high efficacy and low toxicity in studies on mice, and is currently in clinical development.^[1]^[2]

Quick facts Names, Identifiers ...

Close

[1]

[2]

A-423579

References

Related Articles